SEC 13F Intelligence

Acuitas Investments, LLC / ETON

Acuitas Investments, LLC’s Eton Pharmaceuticals Inc Position

Does Acuitas Investments, LLC own Eton Pharmaceuticals Inc (ETON)? Not currently — the last reported position was 185.8K shares worth $2M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2024
Shares
185.8K
% of Portfolio
+2.03%
Quarters Held
8
position exited

Position History ETON

Reported value by quarter
Q1 ’23: $2MQ1 ’23Q2 ’23: $2MQ2 ’23Q3 ’23: $913,230Q3 ’23Q4 ’23: $2MQ4 ’23Q1 ’24: $2MQ1 ’24Q2 ’24: $2MQ2 ’24Q3 ’24: $3MQ3 ’24Q4 ’24: $2MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024185.8K$2M+2.03%
Q3 2024580.0K$3M+1.55%
Q2 2024580.0K$2M+1.02%
Q1 2024580.0K$2M+1.10%
Q4 2023492.1K$2M+1.13%
Q3 2023219.0K$913,230+0.54%
Q2 2023510.1K$2M+1.04%
Q1 2023468.7K$2M+1.86%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acuitas Investments, LLC’s full portfolio or all institutional holders of ETON.